Inactive Instrument

Transcripts A.P. Pharma, Inc. Other OTC

Equities

US00202J2033

End-of-day quote Other OTC Other stock markets
- ^USD	-

02/07	Heron Reports Acceptance of Prior Approval Supplement Application for Zynrelef Vial Access Needle	MT
02/07	Heron Therapeutics, Inc. Announces Acceptance of the Prior Approval Supplement Application for Zynrelef® Vial Access Needle	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Heron Therapeutics, Inc. - Analyst/Investor Day	15/05
Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024	07/05
Transcript : Heron Therapeutics, Inc., Q4 2023 Earnings Call, Mar 12, 2024	13/03
Transcript : Heron Therapeutics, Inc., Q3 2023 Earnings Call, Nov 14, 2023	15/11
Transcript : Heron Therapeutics, Inc., Q2 2023 Earnings Call, Aug 14, 2023	15/23/15
Transcript : Heron Therapeutics, Inc., Q1 2023 Earnings Call, May 11, 2023	12/23/12
Transcript : Heron Therapeutics, Inc., Q4 2022 Earnings Call, Mar 23, 2023	24/23/24
Transcript : Heron Therapeutics, Inc., Q3 2022 Earnings Call, Nov 08, 2022	09/22/09
Transcript : Heron Therapeutics, Inc. - Special Call	19/22/19
Transcript : Heron Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022	09/22/09
Transcript : Heron Therapeutics, Inc., Q1 2022 Earnings Call, May 09, 2022	10/22/10
Heron Therapeutics, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2022	10/22/10	CI
Transcript : Heron Therapeutics, Inc., Q4 2021 Earnings Call, Feb 28, 2022	01/22/01
Heron Therapeutics, Inc. Provides Sales Guidance for the First Quarter of 2022	01/22/01	CI
Transcript : Heron Therapeutics, Inc. - Special Call	09/21/09
Transcript : Heron Therapeutics, Inc., Q3 2021 Earnings Call, Nov 03, 2021	04/21/04
Heron Therapeutics, Inc. Provides Sales Guidance for the Fourth Quarter of 2021	04/21/04	CI
Heron Therapeutics, Inc. Provides Sales Guidance for the Third Quarter of 2021	09/21/09	CI
Transcript : Heron Therapeutics, Inc. - Special Call	13/21/13
Heron Therapeutics, Inc. Provides Sales Guidance for the Full Year 2021	10/21/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts A.P. Pharma, Inc. Other OTC

Equities

US00202J2033

Transcripts

Filters